Role of Citrate in Pathophysiology and Medical Management of Bone Diseases

被引:67
作者
Granchi, Donatella [1 ]
Baldini, Nicola [1 ,2 ]
Ulivieri, Fabio Massimo [3 ]
Caudarella, Renata [4 ]
机构
[1] IRCCS Ist Ortoped Rizzoli, Lab Orthoped Pathophysiol & Regenerat Med, Via Barbiano 1-10, I-40136 Bologna, Italy
[2] Univ Bologna, Dept Biomed & Neuromotor Sci, Via Pupilli 1, I-40136 Bologna, Italy
[3] IRCCS Ca Granda Osped Maggiore Policlin, Bone Metab Unit, Nucl Med, Via F Sforza 35, I-20122 Milan, Italy
[4] Maria Cecilia Hosp, GVM Care & Res, Via Corriera 1, I-48033 Cotignola, RA, Italy
关键词
bone metabolism; bone mineral density; bone remodelling; citrate supplement; osteopenia; osteoporosis; kidney diseases; AMORPHOUS CALCIUM-PHOSPHATE; ACID-BASE STATUS; POTASSIUM CITRATE; CITRIC-ACID; URINARY CITRATE; POSTMENOPAUSAL WOMEN; MITOCHONDRIAL ACONITASE; OSTEOPOROTIC FRACTURE; APATITE NANOCRYSTALS; PARATHYROID-HORMONE;
D O I
10.3390/nu11112576
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Citrate is an intermediate in the "Tricarboxylic Acid Cycle" and is used by all aerobic organisms to produce usable chemical energy. It is a derivative of citric acid, a weak organic acid which can be introduced with diet since it naturally exists in a variety of fruits and vegetables, and can be consumed as a dietary supplement. The close association between this compound and bone was pointed out for the first time by Dickens in 1941, who showed that approximately 90% of the citrate bulk of the human body resides in mineralised tissues. Since then, the number of published articles has increased exponentially, and considerable progress in understanding how citrate is involved in bone metabolism has been made. This review summarises current knowledge regarding the role of citrate in the pathophysiology and medical management of bone disorders.
引用
收藏
页数:30
相关论文
共 153 条
[21]   Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells [J].
Costello, LC ;
Liu, YY ;
Franklin, RB ;
Kennedy, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :28875-28881
[22]  
Costello Leslie C, 2014, J Regen Med Tissue Eng, V3, P4
[23]  
Costello Leslie C, 2012, Open Bone J, V4, DOI 10.2174/1876525401204010027
[24]  
Costello Leslie C, 2013, J Regen Med Tissue Eng, V2
[25]   Bartter syndrome: causes, diagnosis, and treatment [J].
Cunha, Tamara da Silva ;
Heilberg, Ita Pfeferman .
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2018, 11 :291-301
[26]   Rethinking Bone Disease in Kidney Disease [J].
Damasiewicz, Matthew J. ;
Nickolas, Thomas L. .
JBMR PLUS, 2018, 2 (06) :309-322
[27]   Citrate bridges between mineral platelets in bone [J].
Davies, Erika ;
Mueller, Karin H. ;
Wong, Wai Ching ;
Pickard, Chris J. ;
Reid, David G. ;
Skepper, Jeremy N. ;
Duer, Melinda J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (14) :E1354-E1363
[28]   Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women [J].
Dawson-Hughes, B ;
Harris, SS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (04) :773-779
[29]   Effect of calcium and vitamin D supplementation on bone, density in men and women 65 years of age or older [J].
DawsonHughes, B ;
Harris, SS ;
Krall, EA ;
Dallal, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :670-676
[30]   A CONTROLLED TRIAL OF THE EFFECT OF CALCIUM SUPPLEMENTATION ON BONE-DENSITY IN POSTMENOPAUSAL WOMEN [J].
DAWSONHUGHES, B ;
DALLAL, GE ;
KRALL, EA ;
SADOWSKI, L ;
SAHYOUN, N ;
TANNENBAUM, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (13) :878-883